Condensed Balance Sheets - USD ($)		Sep. 30, 2023	Dec. 31, 2022
ASSETS
Cash at bank		$ 735,412	$ 77,709
Prepayment		314,275	2,598
Total current assets		1,049,687	80,307
Deferred offering costs			114,500
Cash and investments held in trust account		152,764,949
TOTAL ASSETS		153,814,636	194,807
Current liabilities:
Total current liabilities		30,000	173,573
Deferred underwriting compensation		2,990,000
TOTAL LIABILITIES		3,020,000	173,573
Common stock, subject to conversion 14,950,000 shares (at conversion value of $10.22 per share)		152,764,949
Shareholders’ equity:
Common stock, $0.0001 par value; 500,000,000 shares authorized; 4,416,075 and 3,737,500 shares issued and outstanding as of September 30, 2023 and December 31, 2022, respectively (excluding 14,950,000 and 0 shares subject to possible redemption)(1)	[1]	442	374
Additional paid-in capital			24,626
Accumulated other comprehensive income		1,396,198
Accumulated deficit		(3,366,953)	(3,766)
Total Shareholders’ (Deficit) Equity	[2]	(1,970,313)	21,234
TOTAL LIABILITIES, TEMPORARY EQUITY AND SHAREHOLDERS’ (DEFICIT) EQUITY		153,814,636	194,807
Related Party
Current liabilities:
Promissory note - related party			173,573
Amount due to a related party		$ 30,000

[1] Includes up to an aggregate of 487,500 ordinary shares subject to forfeiture to the extent that the underwriters’ over-allotment option is not exercised in full or in part (see Note 5). As a result of the underwriters’ full exercise of their over-allotment option on July 27, 2023, no founder shares are currently subject to forfeiture.

[2] Includes up to an aggregate of 487,500 ordinary shares subject to forfeiture to the extent that the underwriters’ over-allotment option is not exercised in full or in part (see Note 5). As a result of the underwriters’ full exercise of their over-allotment option on July 27, 2023, no founder shares are currently subject to forfeiture.